Favorable effects of alemtuzumab on allospecific regulatory T-cell generation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Favorable effects of alemtuzumab on allospecific regulatory T-cell generation

Published:2012-02 Issue:2 Volume:73 Page:141-149
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Levitsky Josh,Leventhal Joseph R.,Miller Joshua,Huang Xuemei,Chen Li,Chandrasekaran Dhivya,Tambur Anat R.,Mathew James M.

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference21 articles.

1. Finding the right job for the tool: Alemtuzumab and its role in renal transplantation;Newell;Am J Transplant,2008

2. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells;Morales;Transplant Proc,2008

3. Prope tolerance, perioperative Campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients;Calne;Lancet,1998

4. Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation;Tzakis;Transplantation,2004

5. “Prope” tolerance: induction, lymphocyte depletion with minimal maintenance;Calne;Transplantation,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell Therapies;Clinical Pharmacology & Therapeutics;2024-03-19

2. Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients;BMJ Open;2022-04

3. Donor T cells for CAR T cell therapy;Biomarker Research;2022-04-01

4. Allogeneic CAR Cell Therapy—More Than a Pipe Dream;Frontiers in Immunology;2021-01-08

5. Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro;American Journal of Transplantation;2019-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3